$3.02
-0.10[-3.21%]
At close: Apr 24
$3.02
0[0.00%]
After Hours: 4:52PM EDT
First Wave BioPharma
(NASDAQ:FWBI)First Wave BioPharma Stock (NASDAQ:FWBI), Analyst Ratings, Price Targets, Predictions
First Wave BioPharma Inc has a consensus price target of $11.25, established from looking at the 17 latest analyst ratings. The last 3 analyst ratings were released from HC Wainwright & Co., Roth MKM, and Roth MKM on March 25, 2024, March 15, 2024, and January 3, 2024. With an average price target of $25.33 between HC Wainwright & Co., Roth MKM, and Roth MKM, there's an implied 738.85% upside for First Wave BioPharma Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
HC Wainwright & Co.
Roth MKM
Roth Capital
Maxim Group
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for First Wave BioPharma
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 03/25/2024 | FWBI | Buy Now | First Wave BioPharma | $3.02 | — | HC Wainwright & Co. | Yi Chen | — | Reinstates | → Neutral | Get Alert |
| 03/15/2024 | FWBI | Buy Now | First Wave BioPharma | $3.02 | 1092.05% | Roth MKM | Jonathan Aschoff | $40 → $36 | Maintains | Buy | Get Alert |
| 01/03/2024 | FWBI | Buy Now | First Wave BioPharma | $3.02 | 1224.5% | Roth MKM | Jonathan Aschoff | $11 → $40 | Maintains | Buy | Get Alert |
| 09/19/2023 | FWBI | Buy Now | First Wave BioPharma | $3.02 | 264.24% | Roth MKM | Jonathan Aschoff | → $220 | Reiterates | Buy → Buy | Get Alert |
| 07/14/2023 | FWBI | Buy Now | First Wave BioPharma | $3.02 | — | HC Wainwright & Co. | Yi Chen | — | Downgrade | Buy → Neutral | Get Alert |
| 06/29/2023 | FWBI | Buy Now | First Wave BioPharma | $3.02 | 231.13% | HC Wainwright & Co. | Yi Chen | → $200 | Reiterates | Buy → Buy | Get Alert |
| 06/13/2023 | FWBI | Buy Now | First Wave BioPharma | $3.02 | 231.13% | HC Wainwright & Co. | Yi Chen | → $200 | Reiterates | Buy → Buy | Get Alert |
| 05/15/2023 | FWBI | Buy Now | First Wave BioPharma | $3.02 | 231.13% | HC Wainwright & Co. | Yi Chen | $280 → $200 | Reiterates | Buy → Buy | Get Alert |
| 04/26/2023 | FWBI | Buy Now | First Wave BioPharma | $3.02 | 363.58% | HC Wainwright & Co. | Yi Chen | → $280 | Reiterates | → Buy | Get Alert |
| 04/05/2023 | FWBI | Buy Now | First Wave BioPharma | $3.02 | 363.58% | HC Wainwright & Co. | Yi Chen | $360 → $280 | Maintains | Buy | Get Alert |
| 03/09/2023 | FWBI | Buy Now | First Wave BioPharma | $3.02 | 496.03% | HC Wainwright & Co. | Yi Chen | → $360 | Reiterates | → Buy | Get Alert |
| 02/03/2023 | FWBI | Buy Now | First Wave BioPharma | $3.02 | 496.03% | HC Wainwright & Co. | Yi Chen | → $360 | Reiterates | → Buy | Get Alert |
| 01/31/2023 | FWBI | Buy Now | First Wave BioPharma | $3.02 | 496.03% | HC Wainwright & Co. | Yi Chen | → $360 | Reiterates | → Buy | Get Alert |
| 01/26/2023 | FWBI | Buy Now | First Wave BioPharma | $3.02 | 496.03% | HC Wainwright & Co. | Yi Chen | → $360 | Reiterates | → Buy | Get Alert |
| 12/02/2022 | FWBI | Buy Now | First Wave BioPharma | $3.02 | 32.45% | HC Wainwright & Co. | Yi Chen | $7840 → $3920 | Maintains | Buy | Get Alert |
| 05/26/2022 | FWBI | Buy Now | First Wave BioPharma | $3.02 | 198.01% | Roth Capital | Jonathan Aschoff | $588000 → $264600 | Maintains | Buy | Get Alert |
| 12/07/2021 | FWBI | Buy Now | First Wave BioPharma | $3.02 | — | Maxim Group | Naz Rahman | — | Downgrade | Buy → Hold | Get Alert |
FAQ
What is the target price for First Wave BioPharma (FWBI)?
The latest price target for First Wave BioPharma (NASDAQ: FWBI) was reported by HC Wainwright & Co. on March 25, 2024. The analyst firm set a price target for $0.00 expecting FWBI to fall to within 12 months (a possible -100.00% downside). 9 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for First Wave BioPharma (FWBI)?
The latest analyst rating for First Wave BioPharma (NASDAQ: FWBI) was provided by HC Wainwright & Co., and First Wave BioPharma their neutral rating.
When was the last upgrade for First Wave BioPharma (FWBI)?
There is no last upgrade for First Wave BioPharma.
When was the last downgrade for First Wave BioPharma (FWBI)?
The last downgrade for First Wave BioPharma Inc happened on July 14, 2023 when HC Wainwright & Co. changed their price target from N/A to N/A for First Wave BioPharma Inc.
When is the next analyst rating going to be posted or updated for First Wave BioPharma (FWBI)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of First Wave BioPharma, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for First Wave BioPharma was filed on March 25, 2024 so you should expect the next rating to be made available sometime around March 25, 2025.
Is the Analyst Rating First Wave BioPharma (FWBI) correct?
While ratings are subjective and will change, the latest First Wave BioPharma (FWBI) rating was a with a price target of $0.00 to $0.00. The current price First Wave BioPharma (FWBI) is trading at is $3.02, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.